Latest Earnings Analysis
-
BlackSky (BKSY) Q4 2023: Backlog Surges to $260M as International Demand Lifts Visibility
February 28, 2024 · BKSY
-
ADT (ADT) Q4 2023: Free Cash Flow Set to Surge 40% as Core Security Focus Sharpens
February 28, 2024 · ADT
-
Royal Bank of Canada (RY) Q1 2024: Commercial Loan Growth Hits 14%, Offsetting Credit Pressure
February 28, 2024 · RY
-
AAP Q4 2023: $150M Cost Outlays and Supply Chain Overhaul Signal Multi-Year Margin Rebuild
February 28, 2024 · AAP
-
Acadia Healthcare (ACHC) Q4 2023: Medicaid Share Rises to 56.8% as Bed Expansion Accelerates
February 28, 2024 · ACHC
-
BRP Group (BWIN) Q4 2023: UCTS Organic Growth Hits 22% as Margin Expansion Accelerates
February 28, 2024 · BWIN
-
AMC (AMC) Q4 2023: Distribution Push Drives 11.5% Revenue Uptick as Content Control Shifts
February 28, 2024 · AMC
-
Bain Capital Specialty Finance (BCSF) Q4 2023: Special Dividends Total $0.12 as Undistributed Income Doubles
February 28, 2024 · BCSF
-
Bandwidth (BAND) Q4 2023: Commercial Messaging Jumps 32% as Enterprise Pipeline Deepens
February 28, 2024 · BAND
-
ACMR Q4 2023: China Sales Drive 43% Annual Growth, International Traction Remains Nascent
February 28, 2024 · ACMR
-
ARKO (ARKO) Q4 2023: Loyalty Members Up 730K, Margin Expansion Anchors Organic Growth Focus
February 28, 2024 · ARKO
-
Blackstone Secured Lending (BXSL) Q4 2023: Pipeline Doubles as Deployment Hits $1B on M&A Resurgence
February 28, 2024 · BXSL
-
Atea Pharmaceuticals (AVIR) Q4 2023: Sunrise-3 Enrollment Surpasses 1,400, Unlocking COVID and HCV Milestone Cadence
February 28, 2024 · AVIR
-
Alchemy Technology (ALKT) Q4 2023: Backlog Climbs 28% as Multi-Year Bank Push Accelerates
February 28, 2024 · ALKT
-
Astronics (ATRO) Q4 2023: Aerospace Drives 23% Revenue Surge as Backlog and Margin Visibility Improve
February 28, 2024 · ATRO
-
Baidu (BIDU) Q4 2023: GenAI Revenue Jumps to 656M RMB, LLM Adoption Accelerates
February 28, 2024 · BIDU
-
Ameresco (AMRC) Q4 2023: Backlog Climbs 50%, Locking in $7B Multi-Year Revenue Visibility
February 28, 2024 · AMRC
-
C3.ai (AI) Q3 2024: Customer Engagements Surge 80% as Generative AI Pipeline Expands
February 28, 2024 · AI
-
Astec Industries (ASTE) Q4 2023: Gross Margin Expands 610bps as Operational Initiatives Take Hold
February 28, 2024 · ASTE
-
Assured Guaranty (AGO) Q4 2023: 84.7% BBB Penetration Signals Insurance Demand Inflection
February 28, 2024 · AGO
-
APG (APG) Q4 2023: Service Revenue Mix Hits 60% Target, Margin Expansion Drives 100bps Gain
February 28, 2024 · APG
-
BBSI (BBSI) Q3 2023: Staffing Revenue Down 25% as PEO Pipeline Hits Record High
February 28, 2024 · BBSI
-
Rapid Microbiosystems (RPID) Q4 2024: Gross Margin Turns Positive, Millipore Sigma Partnership Sets Up 2026 Step-Change
February 28, 2024 · RPID
-
BATRA Q4 2023: Formula One Revenue Jumps 25% as Vegas GP Drives Hospitality Expansion
February 28, 2024 · BATRA
-
Horizon Technology Finance (AVTX) Q4 2023: Portfolio Yield Climbs to 16.8% as Venture Market Stays Stressed
February 28, 2024 · AVTX
-
AAON (AAON) Q4 2023: Data Center Bookings Hit 20% of Orders, Driving Capacity Investments
February 28, 2024 · AAON
-
Accel Entertainment (ACEL) Q4 2023: CapEx Drops 20% as Expansion in Developing Markets Accelerates
February 28, 2024 · ACEL
-
Butterfly Network (BFLY) Q4 2023: $170M Cost Outlays Reset, IQ3 Launch Unlocks Hospital Pipeline
February 28, 2024 · BFLY
-
AESI Q4 2023: High Crush Deal Adds 12M Tons Capacity, Elevates Permian Scale
February 27, 2024 · AESI
-
Agilent (A) Q1 2024: Services Contracts Drive Double-Digit Growth as Instruments Drop 20%
February 27, 2024 · A
-
AutoZone (AZO) Q2 2024: Mega Hub Count Surges to 101, Fueling Commercial Growth Ambitions
February 27, 2024 · AZO
-
American Tower (AMT) Q4 2023: CoreSite Data Center CapEx Rises to $450M as Developed Market Focus Intensifies
February 27, 2024 · AMT
-
Alignment Healthcare (ALHC) Q4 2023: Membership Surges 37% as Clinical Model Drives Utilization Advantage
February 27, 2024 · ALHC
-
Elector (ALEC) Q4 2023: $548M Cash Runway Extends Beyond Late-Stage Data Catalysts
February 27, 2024 · ALEC
-
Arcutis (ARQT) Q4 2023: Zoryve Foam Launch Drives 67% Sequential Revenue Growth, Expanding Addressable Market
February 27, 2024 · ARQT
-
AirSculpt Technologies (AIRS) Q4 2023: 17% Revenue Growth Anchored by De Novo Expansion, Margin Focus Signals Path to $50M EBITDA
February 27, 2024 · AIRS
-
Albany International (AIN) Q4 2023: Heimbach Adds $36M, Integration Drives Double-Digit Revenue Growth
February 27, 2024 · AIN
-
Array Technologies (ARRY) Q4 2023: Bookings Surge to $600M as Margin Expansion Outpaces Revenue Dip
February 27, 2024 · ARRY
-
AdaptHealth (AHCO) Q4 2023: Sleep Resupply Census Hits 1.55 Million, Driving Margin Expansion
February 27, 2024 · AHCO
-
AES (AES) Q4 2023: U.S. Renewables Returns Rise 200bps as Data Center Demand Reshapes Portfolio
February 27, 2024 · AES
-
AEP (AEP) Q4 2023: Data Center Load Drives 7.8% Commercial Growth, Reshaping Demand Profile
February 27, 2024 · AEP
-
ADUS Q4 2023: Personal Care Revenue Reaches 74% Mix on 11.2% Organic Growth
February 27, 2024 · ADUS
-
ADTRAN (ADTN) Q4 2023: Services Climb to 20% of Revenue as Fiber Portfolio Expands
February 27, 2024 · ADTN
-
BWXT (BWXT) Q4 2023: Medical Revenue Jumps 25% as Isotope Pipeline Accelerates
February 27, 2024 · BWXT
-
ASTH Q4 2023: Full Risk Capitation Rises to 49%, Accelerating Value-Based Margin Leverage
February 27, 2024 · ASTH
-
Alphatec (ATEC) Q4 2023: Surgical Revenue Jumps 34% as Clinical Distinction Drives 25%+ Share in Key Markets
February 27, 2024 · ATEC
-
Bumble (BMBL) Q4 2023: $55M Cost Reset Fuels App Relaunch and AI Investment
February 27, 2024 · BMBL
-
Acadia Pharmaceuticals (ACAD) Q4 2023: Debut Drives 69% Revenue Surge, Expanding Rare Disease Platform
February 27, 2024 · ACAD
-
CrossAmerica Partners (CAPL) Q4 2023: Retail Gross Profit Climbs 18% Amid Margin Expansion and Site Growth
February 27, 2024 · CAPL
-
Ambarella (AMBA) Q4 2024: AI SoC ASPs Jump 15% as Edge Inference Strategy Gains Traction
February 27, 2024 · AMBA